BioCentury
ARTICLE | Company News

Management tracks: Astellas, Blueprint

February 6, 2019 8:28 PM UTC

Astellas Pharma Inc. (Tokyo:4503) said President of Pharmaceutical Technology Mitsunori Matsuda and President of Asia & Oceania Business Masatoshi Kuroda will resign, effective June 18. Hideki Shima will succeed Matsuda.

Cancer and rare diseases company Blueprint Medicines Corp. (NASDAQ:BPMC) promoted Michael Landsittel to CFO from VP of finance and Kathryn Haviland to COO from CBO. The precision therapy company said both will continue in their prior roles...